Correspondence 0001628280-24-031482 from INTENSITY THERAPEUTICS, INC. (INTS)
INTENSITY THERAPEUTICS, INC.
Date: July 9, 2024 · CIK: 0001567264 · Accession: 0001628280-24-031482
AI Filing Summary & Sentiment
File numbers found in text: 333-280684
Letter
Document
INTENSITY THERAPEUTICS, INC.
1 ENTERPRISE DRIVE, SUITE 430
SHELTON, CT 06484
July 9, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
Re:
Intensity Therapeutics, Inc.
Registration Statement on Form S-3
Filed July 3, 2024
File No. 333-280684 (the “Registration Statement”)
Acceleration Request
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Intensity Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Thursday, July 11, 2024, at 4:01p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Jeffrey Schultz or Ivan Blumenthal of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 or (212) 692-6784, respectively, with any questions regarding this request.
Very truly yours,
Intensity Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm Document INTENSITY THERAPEUTICS, INC. 1 ENTERPRISE DRIVE, SUITE 430 SHELTON, CT 06484 July 9, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards Re: Intensity Therapeutics, Inc. Registration Statement on Form S-3 Filed July 3, 2024 File No. 333-280684 (the “Registration Statement”) Acceleration Request Ladies and Gentlemen: In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Intensity Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Thursday, July 11, 2024, at 4:01p.m., Eastern Time, or as soon as thereafter practicable. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please contact Jeffrey Schultz or Ivan Blumenthal of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 or (212) 692-6784, respectively, with any questions regarding this request. Very truly yours, Intensity Therapeutics, Inc. /s/ Lewis H. Bender Lewis H. Bender, President & Chief Executive Officer cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Jeffrey Schultz, Esq. Ivan Blumenthal, Esq.